Skip to main content

Table 6 Dossier unique study evidence by disease category (total = 123)

From: A study of the value of requesting information from drug manufacturers for systematic reviews; 9 years of experience from the drug effectiveness review project

Clinical category

Number of reports

Total studies (mean/review)

Study quality

Good

Fair

Poor

Cardiovascular

3

0 (0)

Dermatology

1

6 (6)

6 (100%)

Endocrinology

3

12 (4)

10 (10.4%)

2 (17%)

Gastrointestinal

2

22 (11)

1

18 (19%)

3

Hepatitis

2

8 (4)

3 (38%)

4 (50%)

1 (13%)

Neurology/pain

5

11 (2)

2 (18%)

7 (64%)

2 (18%)

Psychiatry

6

46 (8)

2 (4.3%)

39 (85%)

5 (11%)

Respiratory

3

18 (9)

1 (5.6%)

12 (67%)

5 (27.8%)